Muhittin Emre Ozdemir

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Structure-based drug design approach is used to design and analyze cytochrome P450 inhibitors for the treatment of prostate cancer. The structural efficiency of inhibitors is measured by the ability of the designed inhibitors to form interactions with atoms in the active site of cytochrome P450 that includes a heme group. Docking studies are conducted to(More)
  • 1